Archives

img-01

Indian Pharmaceutical Industry to Triple by 2020

India has grown into the world’s third largest drug producer in volume and twelfth largest in value, according to India’s Minister of State for Health and Family Welfare on September 10, 2012. With a quickly growing economy and large population, India’s pharmaceutical... Read More

img-01

India: New Clinical Research Regulations

The Central Drug Standard Control Organization (CDSCO) of India is responsible for the regulation of clinical trials. On July 17th, 2012 the CDSCO drafted several amendments to the Drugs and Cosmetics Rules of 1945. The changes are intended to improve supervision over... Read More

img-01

India to Renew Pending Bill on Medical Devices

India’s Ministry of Health (MOH) has renewed its effort to bring a long-pending bill on medical devices to Parliament.  The Ministry recently met with the Federation of Indian Chambers of Commerce and Industry (FICCI), the Association of Indian Manufacturers of Medical Devices... Read More

img-01

India to Bring Drugs under Price Control

The Indian government is planning to restrict drug prices significantly. The Indian government announced that approximately 66% of drugs will be under price limits. Currently, 20% of drugs are under price control. New proposals by the government would extend price controls to... Read More

img-01

India: New Drug Pricing Policy Proposed

India’s Department of Pharmaceuticals (DoP) recently proposed a revision of the National Pharmaceuticals Pricing Policy (NPPP). If approved, the new NPPP will change the way prices are determined for both imported and locally manufactured drugs sold in India. More specifically, the NPPP... Read More

img-01

Asia’s Growing Medical Device Market

Asia is becoming a highly attractive market to Western medical device companies due to its strong economic growth, large population and aging populations. Western medical device companies are encouraged to take advantage of Asia's medical device market. Read More

img-01

India Becoming Attractive Clinical Trial Destination

For Western companies and CROs, India is an increasingly attractive destination for conducting clinical trials. Costs are low, clinical infrastructure in urban areas is becoming more advanced, and many local project managers are trained in international GCP standards. Moreover, the rise of... Read More